Gamma secretase

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
== Gamma Secretase Interaction In Alzheimer's Disease ==
== Gamma Secretase Interaction In Alzheimer's Disease ==
-
'''Gamma-secretase''' (GS) is a multi-subunit protease complex which cleaves many transmembrane proteins; it is known as an intramembrane protease. γ-secretase is highly studied in its cleavage of amyloid precursor protein (APP) releasing beta-amyloid (Aβ peptides) which further oligomerize to form neurofibrillary tangles and plaques in Alzheimer’s disease. <ref name= "mckeon">DOI: 10.1016/B978-012351830-9/50024-X</ref>
+
'''Gamma-secretase''' (GS) is a multi-subunit protease complex which cleaves many transmembrane proteins; it is known as an intramembrane protease. γ-secretase is highly studied in its cleavage of amyloid precursor protein (APP) releasing beta-amyloid (Aβ peptides) which further oligomerize to form neurofibrillary tangles and plaques in Alzheimer’s disease.<ref name= "mckeon">DOI: 10.1016/B978-012351830-9/50024-X</ref>
<StructureSection load='4UIS' size='340' side='right' caption='Caption for this structure' scene=''>
<StructureSection load='4UIS' size='340' side='right' caption='Caption for this structure' scene=''>
This is a default text for your page '''Gamma secretase complex'''. Click above on '''edit this page''' to modify. Be careful with the &lt; and &gt; signs.
This is a default text for your page '''Gamma secretase complex'''. Click above on '''edit this page''' to modify. Be careful with the &lt; and &gt; signs.
Line 7: Line 7:
== Background ==
== Background ==
-
γ-secretase belongs to the family of intramembrane-cleaving proteases (i-CLiPs), which includes the presenilin family of '''aspartyl proteases''', the zinc metalloprotease, site-2 protease family, and the rhomboid family of serine proteases. All i-CLiPs enzymatically cleave their substrates within the plane of the lipid bilayer in a process termed regulated intramembrane proteolysis. γ-secretase is mainly involved in intramembranous proteolysis of type I membrane proteins. It cleaves numerous functionally important proteins, such as Notch, E-cadherin, ErbB4, CD44, tyrosinase, TREM2 and Alcadein, suggesting the participation of γ-secretase in a vast range of biological activities. The best-studied γ-secretase substrates are APP for its roles in Alzheimer’s Disease, and Notch for its importance in development and cell fate determination. <ref name= "zhang">DOI:10.3389/fncel.2014.00427</ref>
+
γ-secretase belongs to the family of intramembrane-cleaving proteases (i-CLiPs), which includes the presenilin family of '''aspartyl proteases''', the zinc metalloprotease, site-2 protease family, and the rhomboid family of serine proteases. All i-CLiPs enzymatically cleave their substrates within the plane of the lipid bilayer in a process termed regulated intramembrane proteolysis. γ-secretase is mainly involved in intramembranous proteolysis of type I membrane proteins. It cleaves numerous functionally important proteins, such as Notch, E-cadherin, ErbB4, CD44, tyrosinase, TREM2 and Alcadein, suggesting the participation of γ-secretase in a vast range of biological activities. The best-studied γ-secretase substrates are APP for its roles in Alzheimer’s Disease, and Notch for its importance in development and cell fate determination.<ref name= "zhang">DOI:10.3389/fncel.2014.00427</ref>
== Structure of Gamma Secretase Complex ==
== Structure of Gamma Secretase Complex ==
-
γ-secretase has been identified as an aspartyl protease accountable for cleaving over 90 integral membrane proteins after they have undergone ectodomain shedding. GS has been characterized as a high molecular weight complex that consists of four essential subunits in a 1:1:1:1 heterodimer <ref name= "carroll">DOI:10.1016/j.brainresbull.2016.04.019</ref>: presenilin (PS, PS1 or PS2), Nicastrin (NCT), anterior pharynx-defective-1 (APH-1), and presenilin enhancer-2 (PEN-2).<ref name= "thompson">DOI:10.1186/1756-6606-4-3</ref>
+
γ-secretase has been identified as an aspartyl protease accountable for cleaving over 90 integral membrane proteins after they have undergone ectodomain shedding. GS has been characterized as a high molecular weight complex that consists of four essential subunits in a 1:1:1:1 heterodimer<ref name= "carroll">DOI:10.1016/j.brainresbull.2016.04.019</ref>: presenilin (PS, PS1 or PS2), Nicastrin (NCT), anterior pharynx-defective-1 (APH-1), and presenilin enhancer-2 (PEN-2).<ref name= "thompson">DOI:10.1186/1756-6606-4-3</ref>
-
PSs play a very significant role in AD and is considered a vital catalytic subunit in γ-secretase. PS are multi-transmembrane proteins with nine transmembrane helixes; it is assumed the amino-terminus is located in the cytosol while the carboxyl-terminus is exposed to the luminal/extracellular space. Functional PS requires endoproteolytic cleavage between TM6 and TM7 which generates a 27–28 kDa amino-terminal fragment (NTF) and a 16–17 kDa carboxyl-terminal fragment (CTF). <ref name="zhang" /> The two aspartyl residues in PS1 and PS2 ('''D257''' in TM 6 and at '''D385''' in TM 7) play crucial roles in intramembranous cleavage and AD plaque formation; substitutions of these residues reduces cleavage of APP and Notch1 proteins. <ref name= "o'brien">DOI:10.1146/annurev-neuro-061010-113613</ref> PS, NTF, and CTF bind to form stable and active PS heterodimers at a 1:1 stoichiometry. <ref name="zhang" />
+
PSs play a very significant role in AD and is considered a vital catalytic subunit in γ-secretase. PS are multi-transmembrane proteins with nine transmembrane helixes; it is assumed the amino-terminus is located in the cytosol while the carboxyl-terminus is exposed to the luminal/extracellular space. Functional PS requires endoproteolytic cleavage between TM6 and TM7 which generates a 27–28 kDa amino-terminal fragment (NTF) and a 16–17 kDa carboxyl-terminal fragment (CTF). <ref name="zhang" /> The two aspartyl residues in PS1 and PS2 ('''D257''' in TM 6 and at '''D385''' in TM 7) play crucial roles in intramembranous cleavage and AD plaque formation; substitutions of these residues reduces cleavage of APP and Notch1 proteins.<ref name= "o'brien">DOI:10.1146/annurev-neuro-061010-113613</ref> PS, NTF, and CTF bind to form stable and active PS heterodimers at a 1:1 stoichiometry. <ref name="zhang" />
-
The remaining three subunits (NCT, APH-1, PEN-2) help with stabilizing GS by forming a mature enzyme. NCT contains a large extracellular (or ectodomain) domain, transmembrane helix, and smaller cytoplasmic domain. <ref name= "carroll" />The ectodomain of NCT recognizes and binds to the amino-terminal stubs of previously cleaved transmembrane proteins. APH-1 aids the formation of a pre-complex, which interacts with PS1 or PS2 <ref name= "o'brien" />; it contains two different isoforms from two paralogous genes on chromosomes 1 '''(APH-1A)''' and 15 '''(APH-1B)'''. While PEN-2 works in enzyme maturation <ref name= "carroll" />; it enters the formed complex to initiate the cleavage of PS1 or PS2 to form an N-terminal 28-kDa fragment and a C-terminal 18-kDa fragment, both APH-1 and PEN-2 are critical to the γ-secretase complex. <ref name= "o'brien" />The γ-secretase complex has a molecular weight of approximately 170 kDa, with an additional 30–70 kDa derived from NCT glycosylation, reaching a total size of about 230 kDa with 19 TMs. <ref name= "zhang" />
+
The remaining three subunits (NCT, APH-1, PEN-2) help with stabilizing GS by forming a mature enzyme. NCT contains a large extracellular (or ectodomain) domain, transmembrane helix, and smaller cytoplasmic domain.<ref name= "carroll" />The ectodomain of NCT recognizes and binds to the amino-terminal stubs of previously cleaved transmembrane proteins. APH-1 aids the formation of a pre-complex, which interacts with PS1 or PS2<ref name= "o'brien" />; it contains two different isoforms from two paralogous genes on chromosomes 1 '''(APH-1A)''' and 15 '''(APH-1B)'''. While PEN-2 works in enzyme maturation<ref name= "carroll" />; it enters the formed complex to initiate the cleavage of PS1 or PS2 to form an N-terminal 28-kDa fragment and a C-terminal 18-kDa fragment, both APH-1 and PEN-2 are critical to the γ-secretase complex.<ref name= "o'brien" /> The γ-secretase complex has a molecular weight of approximately 170 kDa, with an additional 30–70 kDa derived from NCT glycosylation, reaching a total size of about 230 kDa with 19 TMs.<ref name= "zhang" />
== Function ==
== Function ==
Once all of the subunits are present, the complex must be correctly assembled for γ-secretase to function properly. The complex is first assembled in the endoplasmic reticulum.
Once all of the subunits are present, the complex must be correctly assembled for γ-secretase to function properly. The complex is first assembled in the endoplasmic reticulum.
-
The events leading to the formation of a mature γ-secretase complex start from the formation of an initial scaffolding complex composed of APH-1 and NCT. Once the scaffold is created, the full-length PS can attach itself.<ref name= "mckeon" />The proximal C-terminus of the PS holoprotein binds to the APH-1-NCT subcomplex by interacting with the TM domain of NCT. Following PS binding, PEN-2 is incorporated into the complex by interacting with TM4 of PS. At the final step, the '''loop domain''' between TM6 and TM7 of PS is cleaved by endoproteolysis. Alternatively, the APH-1-NCT subcomplex may bind directly to a cognate PS1-PEN-2 structure to generate the mature γ-secretase complex.2 <ref name= "zhang" />The active complex is then shuttled to the Golgi where it is glycosylated. Only after the assembly of all four subunits and the glycosylation will GS become active.<ref name= "carroll" />
+
The events leading to the formation of a mature γ-secretase complex start from the formation of an initial scaffolding complex composed of APH-1 and NCT. Once the scaffold is created, the full-length PS can attach itself.<ref name= "mckeon" />The proximal C-terminus of the PS holoprotein binds to the APH-1-NCT subcomplex by interacting with the TM domain of NCT. Following PS binding, PEN-2 is incorporated into the complex by interacting with TM4 of PS. At the final step, the '''loop domain''' between TM6 and TM7 of PS is cleaved by endoproteolysis. Alternatively, the APH-1-NCT subcomplex may bind directly to a cognate PS1-PEN-2 structure to generate the mature γ-secretase complex.<ref name= "zhang" />The active complex is then shuttled to the Golgi where it is glycosylated. Only after the assembly of all four subunits and the glycosylation will GS become active.<ref name= "carroll" />
== Alzheimer's Disease ==
== Alzheimer's Disease ==
-
Although the majority of Aβ is secreted out of the cell, Aβ can be generated in several subcellular compartments within the cell, such as the ER, Golgi/TGN, and endosome/lysosome. In addition, extracellular Aβ can be internalized by the cell for degradation. The intracellular existence of Aβ implies that Aβ may accumulate within neurons and contribute to disease pathogenesis. Confirming this, intraneuronal Aβ immunoreactivity has been found in the hippocampal and entorhinal cortical regions which are prone to early AD pathology in patients with mild cognitive impairment. In Down Syndrome (DS) patients, the accumulation of intracellular Aβ precedes extracellular plaque formation and the level of intraneuronal Aβ decreases as the extracellular Aβ plaques accumulate. Intraneuronal Aβ can also impair amygdala-dependent emotional responses by affecting the ERK/MAPK signaling pathway. Inhibition of dynamin-mediated but not clathrin-mediated Aβ internalization was also found to reduce Aβ-induced neurotoxicity. One recent study suggests that internalized Aβ can aggregate within the cell and disrupt the vesicular membrane, thus contributing to its pathological effect. There are two main toxic species, Aβ40 and Aβ42, with Aβ42 more hydrophobic and more prone to fibril formation while only making up about 10% of the Aβ peptide produced. Studies done on familial AD (FAD) mutations consistently show increases in the ratio of Aβ42/40, suggesting that elevated levels of Aβ42 relative to Aβ40 is critical for AD pathogenesis, probably by providing the core for Aβ assembly into oligomers, fibrils, and amyloidogenic plaques.<ref name="thompson" /> In addition to generating Aβ, γ-secretase cleavage of APP also generates an APP intracellular domain (AICD) within the cell. AICD has been found to possess transcriptional transactivation activity and can regulate the transcription of multiple genes including APP, GSK-3b, KAI1, neprilysin, BACE1, p53, EGFR, and LRP1. In addition, free AICD can induce apoptosis and may play a role in sensitizing neurons to toxic stimuli. <ref name= "zhang" /> However, as the intracellular domain of APP, one important function of AICD is to facilitate the interaction of APP with various cytosolic factors that regulate APP's intracellular trafficking and/or signal transduction function. Interestingly, it seems that AICD-mediated APP interaction with different factors is controlled by the phosphorylation state of AICD. <ref name="thompson" />
+
Although the majority of Aβ is secreted out of the cell, Aβ can be generated in several subcellular compartments within the cell, such as the ER, Golgi/TGN, and endosome/lysosome. In addition, extracellular Aβ can be internalized by the cell for degradation. The intracellular existence of Aβ implies that Aβ may accumulate within neurons and contribute to disease pathogenesis. Confirming this, intraneuronal Aβ immunoreactivity has been found in the hippocampal and entorhinal cortical regions which are prone to early AD pathology in patients with mild cognitive impairment. In Down Syndrome (DS) patients, the accumulation of intracellular Aβ precedes extracellular plaque formation and the level of intraneuronal Aβ decreases as the extracellular Aβ plaques accumulate. Intraneuronal Aβ can also impair amygdala-dependent emotional responses by affecting the ERK/MAPK signaling pathway. Inhibition of dynamin-mediated but not clathrin-mediated Aβ internalization was also found to reduce Aβ-induced neurotoxicity. One recent study suggests that internalized Aβ can aggregate within the cell and disrupt the vesicular membrane, thus contributing to its pathological effect. There are two main toxic species, Aβ40 and Aβ42, with Aβ42 more hydrophobic and more prone to fibril formation while only making up about 10% of the Aβ peptide produced. Studies done on familial AD (FAD) mutations consistently show increases in the ratio of Aβ42/40, suggesting that elevated levels of Aβ42 relative to Aβ40 is critical for AD pathogenesis, probably by providing the core for Aβ assembly into oligomers, fibrils, and amyloidogenic plaques.<ref name="thompson" /> In addition to generating Aβ, γ-secretase cleavage of APP also generates an APP intracellular domain (AICD) within the cell. AICD has been found to possess transcriptional transactivation activity and can regulate the transcription of multiple genes including APP, GSK-3b, KAI1, neprilysin, BACE1, p53, EGFR, and LRP1. In addition, free AICD can induce apoptosis and may play a role in sensitizing neurons to toxic stimuli. <ref name= "zhang" /> However, as the intracellular domain of APP, one important function of AICD is to facilitate the interaction of APP with various cytosolic factors that regulate APP's intracellular trafficking and/or signal transduction function. Interestingly, it seems that AICD-mediated APP interaction with different factors is controlled by the phosphorylation state of AICD.<ref name="thompson" />
== Relevance ==
== Relevance ==

Revision as of 15:41, 8 April 2019

Gamma Secretase Interaction In Alzheimer's Disease

Gamma-secretase (GS) is a multi-subunit protease complex which cleaves many transmembrane proteins; it is known as an intramembrane protease. γ-secretase is highly studied in its cleavage of amyloid precursor protein (APP) releasing beta-amyloid (Aβ peptides) which further oligomerize to form neurofibrillary tangles and plaques in Alzheimer’s disease.[1]

Caption for this structure

Drag the structure with the mouse to rotate

References

  1. 1.0 1.1 doi: https://dx.doi.org/10.1016/B978-012351830-9/50024-X
  2. Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
  3. Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
  4. 4.0 4.1 4.2 4.3 4.4 4.5 Zhang X, Li Y, Xu H, Zhang YW. The gamma-secretase complex: from structure to function. Front Cell Neurosci. 2014 Dec 11;8:427. doi: 10.3389/fncel.2014.00427., eCollection 2014. PMID:25565961 doi:http://dx.doi.org/10.3389/fncel.2014.00427
  5. 5.0 5.1 5.2 5.3 5.4 Carroll CM, Li YM. Physiological and pathological roles of the gamma-secretase complex. Brain Res Bull. 2016 Sep;126(Pt 2):199-206. doi:, 10.1016/j.brainresbull.2016.04.019. Epub 2016 Apr 28. PMID:27133790 doi:http://dx.doi.org/10.1016/j.brainresbull.2016.04.019
  6. 6.0 6.1 6.2 6.3 Zhang YW, Thompson R, Zhang H, Xu H. APP processing in Alzheimer's disease. Mol Brain. 2011 Jan 7;4:3. doi: 10.1186/1756-6606-4-3. PMID:21214928 doi:http://dx.doi.org/10.1186/1756-6606-4-3
  7. 7.0 7.1 7.2 7.3 O'Brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer's disease. Annu Rev Neurosci. 2011;34:185-204. doi: 10.1146/annurev-neuro-061010-113613. PMID:21456963 doi:http://dx.doi.org/10.1146/annurev-neuro-061010-113613
  8. Kelleher RJ 3rd, Shen J. Presenilin-1 mutations and Alzheimer's disease. Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):629-631. doi:, 10.1073/pnas.1619574114. Epub 2017 Jan 12. PMID:28082723 doi:http://dx.doi.org/10.1073/pnas.1619574114
Personal tools